Preclinical evaluation of UCART (allogeneic engineered CAR-T Cells) activity against primary Acute Myeloid Leukemia (AML) samples (CLL Agreement) Grant uri icon

Overview

date/time interval

  • February 20, 2019 - February 19, 2020

sponsor award ID

  • BP 193410-01

Affiliation